ClinicalTrials.gg

EyebioKorea, Inc. clinical trials

Acquired by Merck & Co., Inc, Jul 2024 · source ↗

The registry lists 2 studies whose lead sponsor is EyebioKorea, Inc. 1 is recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 27, 2024.

Before and after it joined Merck & Co., Inc

First submitted before EyebioKorea, Inc. became part of Merck & Co., Inc
2
First submitted after EyebioKorea, Inc. became part of Merck & Co., Inc
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

All 2 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now150%
  • Completed150%

Phase

  • Phase 11
  • Phase 21

Where

  • Korea, Republic of2

Over the years

  1. 122
  2. 23
  3. 24
  4. 25
  5. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • EyebioKorea, Inc.2 studies

Something wrong with this grouping? Tell us on the Merck & Co., Inc page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All Merck & Co., Inc studies →